Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen-Chun Lin

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Diagnostics (Basel, Switzerland)|March 25, 2022
Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial ChemoembolizationPo-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.
Cancers|April 12, 2022
Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct InvasionChing-Hsin Lee, An-Hsin Chen, Sheng-Ping Hung, et al.
The Oncologist|March 26, 2024
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular CarcinomaChung-Wei Su, Wei Teng, Eric Yi-Liang Shen, et al.
Japanese Journal of Radiology|February 5, 2026
Intensity-modulated proton therapy for patients with unresectable giant (≥ 10 cm) hepatocellular carcinoma: a retrospective analysis from two high-volume centersJen-Yu Cheng, Yu-Ming Wang, Yen-Hao Chen, et al.
American Journal of Cancer Research|September 11, 2023
Adding nutritional status to the original BCLC stage improves mortality prediction for hepatocellular carcinoma patients in HBV-endemic regionsYan-Ting Lin, Po-Ting Lin, Chen-Chun Lin, et al.
Plos One|September 12, 2018
How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liverChing-Hsin Lee, Sheng-Ping Hung, Ji-Hong Hong, et al.
Liver Cancer|July 21, 2025
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor AblationMing Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score AnalysisYuan-Hung Kuo, Wei Teng, Po-Ting Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2023
Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective AnalysisRodney Cheng-En Hsieh, Ching-Hsin Lee, Hsiao-Chieh Huang, et al.
Hepatology (Baltimore, Md.)|July 1, 2025
Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in hepatocellular carcinomaChien-Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Diagnostics (Basel, Switzerland)|March 25, 2022
Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial ChemoembolizationPo-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.
Cancers|April 12, 2022
Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct InvasionChing-Hsin Lee, An-Hsin Chen, Sheng-Ping Hung, et al.
The Oncologist|March 26, 2024
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular CarcinomaChung-Wei Su, Wei Teng, Eric Yi-Liang Shen, et al.
Japanese Journal of Radiology|February 5, 2026
Intensity-modulated proton therapy for patients with unresectable giant (≥ 10 cm) hepatocellular carcinoma: a retrospective analysis from two high-volume centersJen-Yu Cheng, Yu-Ming Wang, Yen-Hao Chen, et al.
American Journal of Cancer Research|September 11, 2023
Adding nutritional status to the original BCLC stage improves mortality prediction for hepatocellular carcinoma patients in HBV-endemic regionsYan-Ting Lin, Po-Ting Lin, Chen-Chun Lin, et al.
Plos One|September 12, 2018
How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liverChing-Hsin Lee, Sheng-Ping Hung, Ji-Hong Hong, et al.
Liver Cancer|July 21, 2025
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor AblationMing Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score AnalysisYuan-Hung Kuo, Wei Teng, Po-Ting Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2023
Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective AnalysisRodney Cheng-En Hsieh, Ching-Hsin Lee, Hsiao-Chieh Huang, et al.
Hepatology (Baltimore, Md.)|July 1, 2025
Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in hepatocellular carcinomaChien-Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, et al.
Pageof 10